Rapid AI Stock
Rapid AI is a leader in advanced imaging and workflow solutions for neurovascular, cardiac, and vascular diseases, utilizing artificial intelligence to improve the diagnosis and treatment of these conditions. Their technology, developed from research at the Stanford Stroke Center, provides critical insights for healthcare professionals.
Founded: 2011
For more Rapid AI stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Karim Karti Chief Executive Officer |
| David Stoffel Chief Business Officer |
| Dr. Greg Albers Chairman, Co-Founder and Scientific Lead |
| Dr. Roland Bammer Co-Founder and Technical Advisor |
